MedTrace Logo

Efficacy Study of Intramuscular or Intracoronary Injection of Autologous Bone Marrow Cells to Treat Scarred Myocardium

NCT00560742 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2007-11-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether the administration of patient's own bone marrow cells into scar areas of the heart, can improve the contractile function of these areas.

Conditions

  • Myocardial Infarct
  • Bone Marrow Cells

Interventions

PROCEDURE

Control

Coronary artery bypass grafting without bone marrow cells injection

PROCEDURE

Intramuscular administration of bone marrow cells

Coronary artery bypass grafting, and intramuscular administration of bone marrow cells into myocardial scar

PROCEDURE

Intracoronary administration of bone marrow cells

Coronary artery bypass grafting, and intracoronary administration of bone marrow cells into myocardial scar

Sponsors & Collaborators

  • British Heart Foundation

    collaborator OTHER

  • University Hospitals, Leicester

    lead OTHER

Principal Investigators

  • Manuel Galiñanes, MD PhD FRCS · University Hospitals, Leicester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Completion
2007-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00560742 on ClinicalTrials.gov